The Food and Drug Administration is expected to give emergency use authorization for Johnson & Johnson’s COVID-19 vaccine as early as this weekend. It would be the third vaccine authorized for use in the United States, but the only one that requires just a single dose. In addition, the Johnson & Johnson vaccine does not require the same ultra-cold storage and transportation as the previously authorized Pfizer and Moderna vaccines.
“Should this application be approved, as it appears it may, we have been notified that we should expect an initial shipment of roughly 70,000 doses to be delivered to us next week,” Gov. Phil Murphy said, adding, “Quite simply, an approval of Johnson & Johnson’s application would be a game-changer.” Officials hope that it would make it easier to increase vaccinations among hard-to-reach communities. Correspondent Leah Mishkin reports.